C4x Discovery Share Discussion Threads

[finster007] 30/3/2020 23:42

Toffeeman - ok sympathy gone now pal! Also in SNG but got in at 25p.

I think this will come good again. Early days for me with this one..

[thiopia] 30/3/2020 22:26

This chart suggests a slingshot higher

[albert arthur] 30/3/2020 20:19

100% agree.

[stockhunters] 30/3/2020 19:10

multibagger when market picks up they are involved in covid-19 market cap also tiny

[the stigologist] 30/3/2020 17:14

They need their hard drives checking

[alloa2003] 30/3/2020 16:51

Someone who bought under 10p and is still concerned about the market :)

[the stigologist] 30/3/2020 16:24

What sort of nonce would sell now with this on the cusp of a potential gap closing move ?

[the stigologist] 30/3/2020 15:04

Anything promising is being fast tracked if they have anything they have a public duty to present info let alone duty to investors

[davemac3] 30/3/2020 15:00

it's probably the potential for the NRF-2 compound(s) that's driving this, hopefully trials will show it has some effect in respiratory and viral diseases. Won't be ready for this outbreak but the world will want to be ready for the next one.

[the stigologist] 30/3/2020 14:38

INDV has cooled off because it's not getting relief from DoJ on lawsuit any time soon.

However the US Govt is supporting their INDV2000 clinical trials.

Zero mention of that from so called INDV investors

[amaretto1] 30/3/2020 14:23

U looked at DEV not pharma But in the right place at present.

[toffeeman] 30/3/2020 14:08

Don't feel sorry Finster - I bought SNG at 5.9!

[amaretto1] 30/3/2020 13:54

It will come back .. I'm certain !

[finster007] 30/3/2020 13:25

Feel for you toffeeman! I am up here by a small % but ITX is up 58% today and I Am still 90% on my buy in price. Hate that! Ha

[astorcourt] 30/3/2020 12:03

I bought in here today for small amount, at the top 14.4p.

I guess it will drop now as happens to everything i buy.

[toffeeman] 30/3/2020 12:01

Way to go for those of us in at the funding price of 90p!

[davemac3] 30/3/2020 11:59

could get interesting here, will do a bit more digging



Based on the finding that NRF2 activation slows down HSV-1 infection, the researchers tested the effectiveness of two drugs, Bardoxolone methyl and Sulforaphane, that are known to activate the NRF2 pathway, in preventing an HSV-1 infection from taking place.

They found that when cells were treated with these NRF2 agonists, the virus activated fewer of its own genes and consequentially virus production was impaired. This suggested that NRF2 activation restricts viral infection.

These results suggest a potential opportunity to prevent HSV infection in those with low immune systems. However, the researchers don’t intend to stop there, with plans already in place to use the same method to investigate another type of herpes virus and coronaviruses.

[albert arthur] 30/3/2020 11:27

If all the dots align here as expected, this has potential to be one of the fastest risers on the AIM.

[amaretto1] 30/3/2020 11:13

Not that they are trading at a absolute peanut valuation ? Any man + his dog could see the huge potencial her.

[the stigologist] 30/3/2020 11:08

Because they haven't updated their own Shareholders on news released by INDV

That is a matter of fact

What is speculation is news should be due on NRF2 partnering

Blue sky hype spec would be NRF2 potential for lung diseases/exacerbations caused by covid19

[amaretto1] 30/3/2020 11:06

Serious buys coming here !

[timberwolf3] 30/3/2020 11:06

Starting to move up now, nrf-2 news on the way ?

[seans66] 30/3/2020 11:02

why do you think that?

[the stigologist] 30/3/2020 10:48

Got to be some news coming...

Watch this space